Expression and significance of TGF-β3 and Bcl-2 in uterine myoma tissues
Wei Ze-qing
Abstract
Wei Ze-qing
Abstract
OBJECTIVE:To discuss the expression and significance of TGF-β3 and Bcl-2 in uterine myoma tissues. METHODS:PCR and immunohistochemistry were used to detect TGF-β3,Bcl-2 mRNA and protein expression in 68 cases of uterine uterine myoma and it's adjacent normal uterine smooth muscle tissues. RESULTS:TGF-β3 and BCL-2 mRNA and protein expression in uterine fibroids,whether in luteal phase(0.71±0.30,0.64±0.14) or in proliferative phase (0.72±0.24 ,0.58±0.31)were significantly higher than the same phase in the normal uterine smooth muscle tissues (0.33±0.09,0.27±0.16;0.31±0.11,0.29±0.13),P0.05; The expression of Bcl-2 in leiomyoma cells of the luteal phase (0.64±0.14) was higher than of the proliferative phase (0.58±0.31),P0.05; but there was no significant difference between the two phase in uterine smooth muscle tissues (P0.05);the same as TGF-β3 and Bcl-2 protein in uterine myoma and the normal uterine smooth muscle tissues. CONCLUSION:The change of TGF-β3 and Bcl-2 expressions in uterine leiomyoma tissues were involved in the occurrence and development.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
OBJECTIVE:To discuss the expression and significance of TGF-β3 and Bcl-2 in uterine myoma tissues. METHODS:PCR and immunohistochemistry were used to detect TGF-β3,Bcl-2 mRNA and protein expression in 68 cases of uterine uterine myoma and it's adjacent normal uterine smooth muscle tissues. RESULTS:TGF-β3 and BCL-2 mRNA and protein expression in uterine fibroids,whether in luteal phase(0.71±0.30,0.64±0.14) or in proliferative phase (0.72±0.24 ,0.58±0.31)were significantly higher than the same phase in the normal uterine smooth muscle tissues (0.33±0.09,0.27±0.16;0.31±0.11,0.29±0.13),P0.05; The expression of Bcl-2 in leiomyoma cells of the luteal phase (0.64±0.14) was higher than of the proliferative phase (0.58±0.31),P0.05; but there was no significant difference between the two phase in uterine smooth muscle tissues (P0.05);the same as TGF-β3 and Bcl-2 protein in uterine myoma and the normal uterine smooth muscle tissues. CONCLUSION:The change of TGF-β3 and Bcl-2 expressions in uterine leiomyoma tissues were involved in the occurrence and development.
Key concepts: Leiomyoma, Uterine leiomyoma, Uterine fibroids, Immunohistochemistry, Uterine myoma, Luteal phase, Smooth muscle, Transforming growth factor